Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation. - Wikidata - awgldk - TriplyDB

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.

http://www.wikidata.org/entity/Q44690504

about

Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study.Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis Bleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis.Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis The Safetyof Dabigatran Versus Warfarin in Patients Undergoing Atrial Fibrillation Ablation Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.Perioperative management of oral anticoagulants: a focus on target-specific oral anticoagulants.Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.Post-Procedural Dabigatran Versus Interrupted Warfarin Therapy Following Catheter Ablation for Atrial Fibrillation.Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation.

P2860

Q30814514-1D683A5D-2344-4390-B8D7-1BF9DB76683F Q35026442-C6D18799-5C61-4130-8417-A540ED19CC49 Q35631782-DAEE9F73-60CC-4618-BF21-4AC72C567D34 Q35765335-587E9A01-DCCE-40D1-A977-DFC55D8CD3CA Q36999959-5C489418-883D-4BEB-8BD1-59B7E3BD352D Q37115131-C885C31B-AFA0-48B6-91C9-ADC38014B06A Q37427004-589823AB-589B-4EA4-9F71-1D09870A87F6 Q37552980-80633FA5-610C-468E-8FA1-D4FD9822273E Q38254247-C4B1B5B9-A5B5-44A0-B415-BA9791DCCCB8 Q38262325-E5469EF8-3078-467F-A6DB-15FE876C1232 Q38365022-AEEE62D1-E7A0-4D73-92F0-FFE14B024281 Q38398014-17F3D955-6715-4763-8C23-D22567A5B18B Q38496232-CA243C92-C0F9-4D66-B71A-D9BBCF7CC9B0 Q38541307-BCE03710-F256-4967-855D-5A6CE1B68355 Q38826010-8C809720-1F05-49AB-B15B-F4B6056033EB Q39285809-85D011D6-6581-43CA-8122-8AB795802D5E Q39900127-AC720BDB-BD3E-4FC4-83CB-73E7D2C9BCC9 Q42409132-2855A2CF-4A9F-4444-A5FB-B4554C7BBC69 Q44699178-9948364F-305B-4FBC-B796-77D036EBDA85 Q48351089-5960D096-B4A5-472B-B7C8-1ECC684911A0

P2860

Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.

http://www.wikidata.org/entity/Q44690504

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@en

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@nl

type

label

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@en

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@nl

prefLabel

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@en

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@nl

P1433

Q44690504-8CE5C1F5-DD07-4A2F-8E0A-435D4ADD11CA

P1476

Q44690504-5061105E-B959-4548-80D1-EFC4E9CCBBF7

P2093

Q44690504-1114F075-03DC-4B0B-96AB-196E261E11D7

Q44690504-711F2830-BFD3-4C46-92BF-53878C7A1F4C

Q44690504-994A061F-6275-40ED-8F1D-9E35E8276BF8

Q44690504-A9983E85-0585-404A-90B2-F80CD92A3008

Q44690504-D59308C3-1BCD-4B86-BCEE-133CF304CE1C

Q44690504-DCD3533B-A125-46DA-9104-D5E0B0B3D267

Q44690504-E633DB48-1D03-41EA-85BE-CF9F22C8BC2A

Q44690504-F057874B-EF44-4D9E-A774-C53E2F10B358

P2860

Q44690504-06E22949-0179-4421-8F08-E52384211659

Q44690504-09665581-0B4C-4B54-BFBC-EA55B486CC5D

Q44690504-0AA8844E-90BC-433B-B15E-FADE07EA85C6

Q44690504-0E3ECAFC-67FD-4A9F-B1C3-D53322B4ABEB

Q44690504-19BCF395-2BED-4BEE-BF2E-3BB25C9FD690

Q44690504-436BEF32-6EA7-4AD6-93C9-817F55841999

Q44690504-5D7E00F5-EED4-46BC-80E3-62FED09E3DD9

Q44690504-6C1A1420-1A27-4C79-B180-29FB10D0C0BC

Q44690504-6FB4C594-9F18-4226-9E15-934E2F4A8B10

Q44690504-8100CEDE-FAE0-4015-94CA-FC3FEE97B384

P2888

Q44690504-1F202E05-38CD-46B0-9701-80CE2623A932

P304

Q44690504-74571CA1-44C8-45F3-8F7F-8BDDB88CDB6D

P31

Q44690504-A316AF36-1951-449F-BAB8-695A5595235A

P356

Q44690504-80F758B3-6B47-4064-9684-2535A2965174

P433

Q44690504-30167AED-D170-4A29-B6C7-E18FD6289875

P478

Q44690504-8CBA3D45-0089-4691-BBC5-552D0E2E618B

P50

Q44690504-1AF621E9-A9D7-498B-B208-A1DBEF5C0ED9

Q44690504-CF3508D4-46A1-41F6-B4ED-211F9D7B2273

Q44690504-EEBD4EF8-BFA8-4225-B74E-B8BC3CE3F848

P577

Q44690504-34EDF9C1-CF0A-4A16-96FD-A752884034CA

P698

Q44690504-C1A237E5-2226-4A6D-BFBD-1801EE755DC9

P921

Q44690504-37EED8F2-7404-4F7C-9B40-95D125599E6D

Q44690504-FAF53C75-F95C-4A9A-877B-E9275683AB41

P356

S10840-013-9800-Z

P1433

Journal of Interventional Cardiac Electrophysiology

P1476

Dabigatran versus warfarin ant ...... atment of atrial fibrillation.

@en

P2093

Allan C Skanes

http://www.w3.org/2001/XMLSchema#string

David E Haines

http://www.w3.org/2001/XMLSchema#string

Hirad Yarmohammadi

http://www.w3.org/2001/XMLSchema#string

Koonlawee Nademanee

http://www.w3.org/2001/XMLSchema#string

Michelle Mead-Salley

http://www.w3.org/2001/XMLSchema#string

Miguel Salazar

http://www.w3.org/2001/XMLSchema#string

Montawatt Amnueypol

http://www.w3.org/2001/XMLSchema#string

Pradyot Saklani

http://www.w3.org/2001/XMLSchema#string

P2860

Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography.

Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation.

Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.

Complications of atrial fibrillation ablation: when prevention is better than cure.

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.

P2888

s10840-013-9800-z

P304

233-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10840-013-9800-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Francis E. Marchlinski

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23740224

http://www.w3.org/2001/XMLSchema#string

P921

catheter ablation

anticoagulation